ID   TihoDProAdcarc0846
AC   CVCL_ZV54
SY   DT08/46; Adcarc0846; 0846
DR   GEO; GSM5720792
DR   GEO; GSM5720793
DR   GEO; GSM5720794
DR   GEO; GSM5720795
DR   GEO; GSM5720796
DR   GEO; GSM5720797
DR   GEO; GSM5720798
DR   GEO; GSM5720799
DR   Wikidata; Q98133255
RX   PubMed=24324078;
RX   PubMed=26774145;
RX   PubMed=32168360;
RX   PubMed=34972712;
RX   PubMed=35109825;
CC   Doubling time: 26.2 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: German Roughhaired Pointer; VBO=VBO_0200575.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
RX   PubMed=24324078;
RA   Moulay M., Liu W., Willenbrock S., Sterenczak K.A., Carlson R.,
RA   Ngezahayo A., Murua Escobar H., Nolte I.;
RT   "Evaluation of stem cell marker gene expression in canine prostate
RT   carcinoma- and prostate cyst-derived cell lines.";
RL   Anticancer Res. 33:5421-5431(2013).
//
RX   PubMed=26774145; DOI=10.4149/208_150924N505;
RA   Hammer S.C., Nagel S., Junginger J., Hewicker-Trautwein M., Wagner S.,
RA   Heisterkamp A., Ngezahayo A., Nolte I., Murua Escobar H.;
RT   "Claudin-1, -3, -4 and -7 gene expression analyses in canine prostate
RT   carcinoma and mammary tissue derived cell lines.";
RL   Neoplasma 63:231-238(2016).
//
RX   PubMed=32168360; DOI=10.1371/journal.pone.0230272; PMCID=PMC7069630;
RA   Packeiser E.-M., Hewicker-Trautwein M., Thiemeyer H., Mohr A.,
RA   Junginger J., Schille J.T., Murua Escobar H., Nolte I.;
RT   "Characterization of six canine prostate adenocarcinoma and three
RT   transitional cell carcinoma cell lines derived from primary tumor
RT   tissues as well as metastasis.";
RL   PLoS ONE 15:e0230272.1-e0230272.25(2020).
//
RX   PubMed=34972712; DOI=10.21873/invivo.12688; PMCID=PMC8765162;
RA   Alnajjar S., Nolte I., Schille J.T., Sender S., Trakoolju N.,
RA   Perez S.V., Zechner D., Vollmar B., Junghanss C., Murua Escobar H.;
RT   "Establishment and characterization of FusionRed stable transfected
RT   canine prostate adenocarcinoma and transitional cell carcinoma
RT   cells.";
RL   In Vivo 36:170-179(2022).
//
RX   PubMed=35109825; DOI=10.1186/s12935-021-02422-9; PMCID=PMC8812184;
RA   Packeiser E.-M., Taher L., Kong W.-B., Ernst M., Beck J.,
RA   Hewicker-Trautwein M., Brenig B., Schutz E., Murua Escobar H.,
RA   Nolte I.;
RT   "RNA-seq of nine canine prostate cancer cell lines reveals diverse
RT   therapeutic target signatures.";
RL   Cancer Cell Int. 22:54.1-54.21(2022).
//